Oral manifestation and dental management in a patient with chronic graft versus host disease with around a 10-year follow-up

Authors

  • Hamid Reza Mozaffari Department of Oral and Maxillofacial Medicine, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran; Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Masoud Sadeghi Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran; Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran http://orcid.org/0000-0002-3586-3012
  • Ladan Jamshidy Department of Prosthodontics, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Neda Omidpanah Department of Oral and Maxillofacial Medicine, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Mohammad Shooriabi Department of Oral Medicine, Faculty of Dentistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  • Hedaiat Moradpoor Department of Prosthodontics, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
  • Roohollah Sharifi Department of Endodontics, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran

DOI:

https://doi.org/10.15419/bmrat.v5i6.449

Keywords:

Hematopoietic stem cell transplantation, Graft versus host disease, Oral manifestation, Dental management

Abstract

Chronic graft versus host disease (cGVHD) is a complex entity and major complication following allogenic hematopoietic stem cell transplantation (allo-HSCT). This study was the first to report oral manifestation and dental management in a patient with cGVHD after allo-HSCT with a longterm follow-up. A 40-year-old man referred to Department of Oral and Maxillofacial Medicine with complaints of tongue burning, mouth dryness, and ulcers. He had chronic myelogenous leukemia and had undergone allo-HSCT. The patient had undergone treatment with several sessions of extracorporeal photopheresis. The GVHD complications had started about nine months after HSCT. In conclusion, the dentist should play a role in the local therapy of cases with oral manifestation and dental management of cGVHD. Controlling the GVHD can reduce oral and dental alterations, increase the improvement of the quality of life, and reduce the need for more intensive immunosuppressive systemic therapies.

Author Biography

  • Roohollah Sharifi, Department of Endodontics, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
    roholahsharifi@gmail.com

Published

2018-06-23

Issue

Section

Case report

How to Cite

Oral manifestation and dental management in a patient with chronic graft versus host disease with around a 10-year follow-up. (2018). Biomedical Research and Therapy, 5(6), 2370-2377. https://doi.org/10.15419/bmrat.v5i6.449

Similar Articles

401-410 of 568

You may also start an advanced similarity search for this article.